Ralph J. Abi‐Habib

1.1k citations

32 papers · 857 indexed · h-index 18

Co-authors: Mirvat El‐Sibai Arthur E. Frankel Stephen H. Leppla Shihui Liu Everett Stone Nicholas S. Duesbery Thomas Bugge Ghassan Dbaibo
Topics: Cancer Research and Treatments (11 papers)Virus-based gene therapy research (7 papers)Bacillus and Francisella bacterial research (7 papers)
Cited by: Biotechnology Cancer Research Biochemistry
Journals: Blood Clinical Cancer Research International Journal of Molecular Sciences
Partner nations: Lebanon United States Norway

In The Last Decade

Ralph J. Abi‐Habib

30 papers receiving 840 citations

Peers

Countries citing papers authored by Ralph J. Abi‐Habib

Since Specialization

Citations

This map shows the geographic impact of Ralph J. Abi‐Habib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph J. Abi‐Habib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph J. Abi‐Habib more than expected).

Fields of papers citing papers by Ralph J. Abi‐Habib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph J. Abi‐Habib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph J. Abi‐Habib. The network helps show where Ralph J. Abi‐Habib may publish in the future.

Co-authorship network of co-authors of Ralph J. Abi‐Habib

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph J. Abi‐Habib. A scholar is included among the top collaborators of Ralph J. Abi‐Habib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph J. Abi‐Habib. Ralph J. Abi‐Habib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Key genes altered in glioblastoma based on bioinformatics (Review) 2025 ·Oncology Letters ·(unknown),Nématollah Jaafari,Meir Mouallem,(unknown),Mirvat El‐Sibai,Ralph J. Abi‐Habib	0
2	3D modeling in cancer studies 2021 ·Human Cell ·Oula El Atat,Zahra Farzaneh,Mahsa Pourhamzeh,(unknown),Ralph J. Abi‐Habib,Massoud Vosough,Mirvat El‐Sibai	51
3	Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA 2021 ·Journal of Ovarian Research ·(unknown),Isabelle Fakhoury,(unknown),Ralph J. Abi‐Habib,Mirvat El‐Sibai	14
4	Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells 2020 ·Human Cell ·(unknown),(unknown),Isabelle Fakhoury,(unknown),Jamilah Borjac,Mirvat El‐Sibai,Ralph J. Abi‐Habib	7
5	Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review 2020 ·Cancer Cell International ·(unknown),(unknown),(unknown),Ralph J. Abi‐Habib,Mirvat El‐Sibai	84
6	[HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells 2019 ·Investigational New Drugs ·(unknown),Ralph J. Abi‐Habib	17
7	Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent 2019 ·Investigational New Drugs ·(unknown),Mirvat El‐Sibai,Ralph J. Abi‐Habib	34
8	PO-065 Arginine deprivation through human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000] activates autophagy and leads to autophagy-mediated cell death in glioblastoma cells 2018 ·ESMO Open ·Ralph J. Abi‐Habib,(unknown),(unknown),Mirvat El‐Sibai	1
9	Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion 2016 ·International Journal of Oncology ·(unknown),(unknown),(unknown),(unknown),Shihui Liu,Stephen H. Leppla,Ralph J. Abi‐Habib,Mirvat El‐Sibai	23
10	Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells 2015 ·Journal of Neuro-Oncology ·(unknown),(unknown),Everett Stone,Mirvat El‐Sibai,Arthur E. Frankel,Ralph J. Abi‐Habib	51
11	Wild Carrot Oil Extract is Selectively Cytotoxic to Human Acute Myeloid Leukemia Cells 2015 ·Asian Pacific Journal of Cancer Prevention ·(unknown),(unknown),(unknown),Costantine F. Daher,Ralph J. Abi‐Habib	25
12	Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF) 2015 ·Translational Oncology ·(unknown),(unknown),(unknown),(unknown),Hady Ghanem,(unknown),Marwan Ghosn,Selim Nasser,(unknown),A. R. Bazer‐Bachi,Shihui Liu,Stephen H. Leppla,Arthur E. Frankel,Ralph J. Abi‐Habib	10
13	765: Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells 2014 ·European Journal of Cancer ·(unknown),(unknown),Everett Stone,George Georgiou,A Frankel,Ralph J. Abi‐Habib	2
14	Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells 2013 ·Leukemia Research ·(unknown),(unknown),(unknown),Everett Stone,(unknown),Arthur E. Frankel,Ralph J. Abi‐Habib	42
15	Cytotoxicity of Anthrax Lethal Toxin to Human Acute Myeloid Leukemia Cells Is Nonapoptotic and Dependent on Extracellular Signal-Regulated Kinase 1/2 Activity 2013 ·Translational Oncology ·(unknown),(unknown),(unknown),Shihui Liu,Stephen H. Leppla,Arthur E. Frankel,Ralph J. Abi‐Habib	15
16	Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia 2010 ·European Urology ·Samuel R. Denmeade,Blair Egerdie,Gary Steinhoff,(unknown),Ralph J. Abi‐Habib,Peter Pommerville	49
17	Changes in sphingomyelinases, ceramide, Bax, Bcl2, and caspase-3 during and after experimental status epilepticus 2008 ·Epilepsy Research ·Mohamad A. Mikati,Michele Zeinieh,Ralph J. Abi‐Habib,Jimmy El Hokayem,Amal Rahmeh,Marwan El Sabban,Julnar Usta,Ghassan Dbaibo	24
18	Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity 2007 ·Anti-Cancer Drugs ·(unknown),Jeffrey L. Browning,Ralph J. Abi‐Habib,(unknown),Simon A. Williams,(unknown),Samuel R. Denmeade,Thomas J. Buckley,Arthur E. Frankel	12
19	BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin 2005 ·Molecular Cancer Therapeutics ·Ralph J. Abi‐Habib,(unknown),Shihui Liu,Stephen H. Leppla,Nicholas S. Duesbery,Arthur E. Frankel	57
20	Hippocampal Programmed Cell Death after Status Epilepticus: Evidence for NMDA‐Receptor and Ceramide‐Mediated Mechanisms 2003 ·Epilepsia ·Mohamad A. Mikati,Ralph J. Abi‐Habib,Marwan El Sabban,Ghassan Dbaibo,Rana Kurdi,(unknown),Firas Farhat,(unknown)	72

About Ralph J. Abi‐Habib

Ralph J. Abi‐Habib is a scholar working on Biotechnology, Virology and Biochemistry, having authored 32 papers that have together received 857 indexed citations. Recurring topics across this work include Cancer Research and Treatments (11 papers), Virus-based gene therapy research (7 papers) and Bacillus and Francisella bacterial research (7 papers). The work is most often cited by research in Biotechnology (239 citations), Cancer Research (169 citations) and Biochemistry (53 citations). Ralph J. Abi‐Habib has collaborated with scholars based in Lebanon, United States and Norway. Frequent co-authors include Mirvat El‐Sibai, Arthur E. Frankel, Stephen H. Leppla, Shihui Liu, Everett Stone, Nicholas S. Duesbery, Thomas Bugge, Ghassan Dbaibo, Marwan El Sabban and Mohamad A. Mikati. Their work appears in journals such as Blood, Clinical Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact